NCT00436384
Completed
Not Applicable
Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients
University Health Network, Toronto1 site in 1 country150 target enrollmentStarted: November 2005Last updated:
ConditionsTransplant
Overview
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 150
- Locations
- 1
Overview
Brief Summary
Cytomegalovirus (CMV) is a common cause of illness in patients who have undergone a transplant. Serious infections due to CMV can affect many parts of the body including the lungs, the gut, and the liver. Since transplant recipients are at risk for CMV or have evidence of infection with CMV, they are given an antiviral drug (usually ganciclovir or valganciclovir). Despite this, there are a chance that CMV infection may cause problems in the future. The purpose of this study is to assess how well patients'immune systems responds to the CMV virus, so that in the future it may be possible to predict which patients are at highest risk of CMV.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Male or female patients who fulfill the following criteria are eligible for inclusion.
- •CMV D+/R- liver, kidney and heart recipient
- •CMV R+ liver,kidney and heart recipients who have received thymoglobulin induction therapy.
- •D+/R- and R+ lung transplant recipients.
- •Able to give written informed consent
- •Are willing and able to comply with the protocol
- •Age \>=18 years
Exclusion Criteria
- •Patient unwilling or unable to give informed consent
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Phase 2
CMV Glycoprotein B Vaccine in Allograft RecipientsCytomegalovirus InfectionsNCT00299260University College, London140
Completed
Not Applicable
Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant RecipientsCytomegalovirus InfectionNCT00817908University of Alberta131
Active, not recruiting
Not Applicable
Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ TransplantationCytomegalovirus InfectionsSolid Organ TransplantationNCT05701228University Hospital, Bordeaux552
Completed
Not Applicable
Cytomegalovirus Cell-Mediated ImmunityCytomegalovirus InfectionsNCT00815165National Institute of Allergy and Infectious Diseases (NIAID)165
Completed
Phase 2
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV InfectionKidney TransplantationCMV InfectionNCT04934527University Hospital, Bordeaux42